Please sign in to follow a disease.
Pyruvate dehydrogenase E2 deficiency
MONDO:0009502Pyruvate dehydrogenase E2 deficiency is a very rare form of pyruvate dehydrogenase deficiency (PDHD) characterized by variable lactic acidosis and neurological dysfunction, mainly appearing during childhood.
Also known as: dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex deficiency, dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex deficiency, pyruvate dehydrogenase E2 deficiency, pyruvate dehydrogenase complex component E2 deficiency, PDHDD, lactic acidemia due to defect of E2 lipoyl transacetylase of the pyruvate dehydrogenase Complex
19 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsBroader categories
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
Knowledge-focused Stopped earlyThis study measures levels of a protein called NT-3 in the blood of people with peripheral neuropathy or Charcot-Marie-Tooth disease. Researchers will compare these levels with measures of muscle strength, mobility, and daily function. The goal is to see whether NT-3 levels corre…
Sponsor: Zarife Sahenk • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC